Trypt – Glenmark Pharmaceuticals

Opposed App ID 4723935 Class 5 Word

Trademark information

IP India · live record
Application ID
4723935
Status
Opposed
Sub status
Not Applicable
Date of application
29 October 2020
Classes
5
Type
Word
Proprietor
Glenmark Pharmaceuticals Public B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026
Attorney
Vishesh And Associates[10756]301/302, A Wing, 3 Rd Floor, Shaheen Chambers, Dawood Baug, Opp. Pearl Heritage,Andheri (West), Mumbai 400 058.
State
Maharashtra
Filing mode
e-Filing
IP office
Mumbai
Used since
—
Valid / upto
—

Goods & services

Class 5

Class 5PHARMACEUTICAL, MEDICINAL AND AYURVEDIC PREPARATIONS AND SUBSTANCES, DIETETIC FOOD AND SUBSTANCES ADAPTED FOR MEDICAL USE, DIETARY SUPPLEMENTS FOR HUMANS, NUTRITIONAL SUPPLEMENTS, NUTRACEUTICAL PREPARATIONS FOR THERAPEUTIC OR MEDICAL PURPOSES, NUTRACEUTICALS FOR USE AS DIETARY SUPPLEMENTS

Uploaded documents

Sign in to open
1 TM-A(TRADE MARKS APPLICATION) 29 Oct 2020
2 Reply to Exam Report (MIS-R) 08 Dec 2020
3 Authorization Letter 30 Apr 2022
4 Authorization Letter 05 Jul 2022
5 Authorization Letter 27 May 2023
6 TM-O(NOTICE OF OPPOSITION) 11 Jul 2023
7 Journal Copy 27 Oct 2023
8 Annexure -1 under rule 46 25 Jan 2024
8 Evidence Affidavit Under Rule 46 (TOP) 25 Jan 2024
9 Annexure -1 under rule 46 25 Jan 2024
9 Evidence Affidavit Under Rule 46 (TOP) 25 Jan 2024

Correspondence and notices

1 EXAMINATION REPORT 10683366 13 Nov 2020
2 Hearing Notice (Show Cause) 13186468 15 Mar 2022
3 Hearing Notice (Show Cause) 13543321 25 May 2022
4 Hearing Notice (Show Cause) 15002648 24 Mar 2023
5 Tribunal Accepted Notice for : 4723935 15328899 · 5978644 30 May 2023
6 Opposition Notice 15854341 · 6129872 17 Aug 2023
7 Opposition Counter Statement 16379322 · 6303855 28 Oct 2023

Frequently asked questions

Trypt was applied for on 29 October 2020.

The application was filed by Glenmark Pharmaceuticals.

Class 5.

As per IP India, the status is Opposed.

The listed application ID of Trypt is 4723935.

Trademark attorney Vishesh And Associates.